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Background: To investigate the feasibility and benefits of a modified adaptive radiotherapy (ART) by replanning in
the initial CT (iCT) with new contours from a repeat CT (rCT) based on CT-CT image fusion for nasopharyngeal can-
cer (NPC) patients underwent volumetric modulated arc radiotherapy (VMAT).
Materials and methods: Nine NPC patients underwent VMAT treatment with a rCT at 23rd fraction were enrolled
in this study. Dosimetric differences for replanning VMAT plans in the iCT and in the rCT were compared.
Volumetric and dosimetric changes of gross tumor volume (GTV) and organs at risk (OARs) of this modified ART
were also investigated.
Results: No dosimetric differences between replanning in the iCT and in the rCT were observed. The average
volume of GTV decreased from 78.83 ± 38.42 cm3 in the iCT to 71.44 ± 37.46 cm3 in the rCT, but with no significant
difference (p = 0.42).The average volume of the left and right parotid decreased from 19.91 ± 4.89 cm3 and 21.58 ±
6.16 cm3 in the iCT to 11.80 ± 2.79 cm3 and 13.29 ± 4.17 cm3 in the rCT (both p < 0.01), respectively. The volume of
other OARs did not shrink very much. No significant differences on PTVGTV and PTVCTV coverage were observed for
replanning with this modified ART. Compared to the initial plans, the average mean dose of the left and right
parotid after re-optimization were decreased by 62.5 cGy (p = 0.05) and 67.3 cGy (p = 0.02), respectively, and the V5
(the volume receiving 5 Gy) of the left and right parotids were decreased by 7.8% (p = 0.01) and 11.2% (p = 0.001),
respectively. There was no significant difference on the dose delivered to other OARs.
Conclusion: Patients with NPC undergoing VMAT have significant anatomic and dosimetric changes to parotids.
Repeat CT as an anatomic changes reference and re-optimization in the iCT based on CT-CT image fusion was
accurate enough to identify the volume changes and to ensure safe dose to parotids.
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Deformable registrationIntroduction
Due to its dose painting capability and sharp dose gradi-
ent, intensity modulated radiotherapy (IMRT), and re-
cently developed new IMRT delivery method: volumetric
modulated arc therapy (VMAT), have been accepted as
the primary treatment modalities for nasopharyngeal
cancer (NPC) patients [1,2]. Studies have confirmed that
the dosimetric advantages of IMRT over conventional
treatment translated into clinical outcome with reduced* Correspondence: billy07@wzhospital.cn
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reproduction in any medium, provided the orparotid toxicity [3]. However, geometry and anatomic
changes during the long course of IMRT treatment have
limited the clinical benefits of IMRT [4]. Adaptive radio-
therapy (ART) is a formal approach to correct for daily
tumor and normal tissue variations through online or
offline modification of original IMRT target volumes
and plans [5]. In most of the clinical workflows, the
adaption of the plan occurs in a replanning computed
tomography (CT) on the basis of relevant dosimetric
discrepancies.
One retrospective study demonstrated that repeat CT
(rCT) imaging and IMRT replanning helped to ensureThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Flowchart for the whole study design. iCT is the initial CT; rCT is the repeat CT; SOiCT is the structures on the initial CT; SOrCT is the
structures on the repeat CT; SOr-to-iCT is the structures propagated from the repeat CT on the initial CT.
Table 1 Patients characteristics
Patients Staging GTV volume (cm3) CTV volume (cm3)
1 T2N2Mx 59.61 617.99
2 T2N1Mx 85.49 757.70
3 T3N0M0 62.18 589.08
4 T4N0Mx 170.96 546.76
5 T3N3Mx 92.39 504.18
6 T2N2Mx 64.38 416.45
7 T4N0Mx 83.41 739.74
8 T2N2Mx 45.27 498.05
9 T2N3Mx 45.79 462.43
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mal structures for patients who had clinically identified
anatomic changes during the course of IMRT [6]. It had
been reported that NPC patients can benefit from
replaning before the 25th fraction [7]. The 3-year local
progression-free survival of advanced NPC patients had
also been improved by IMRT replanning [8]. One poten-
tial problem of replanning IMRT with a second CT scan
is the loss of accurate dose accumulation on organs at
risk (OARs) and targets due to several potential discrep-
ancies between the iCT and the rCT. Hybrid IMRT plan
by applying the beam configurations of the first IMRT
plan to the anatomy of the second CT scan was usually
applied to study the accumulated dose on OARs and tar-
get volumes [6-8]. However, the volume of targets and
OARs for hybrid IMRT plan were different from those
in the iCT due to anatomic changes and inherent delin-
eation variations [9,10]. It is hard for physicians to delin-
eate the same superior and inferior boundary of targets
in two different CT sets. It might also introduce add-
itional errors during the transmission of the beam con-
figuration due to the beam isocenter displacement
resulted from volume changes. Therefore, the accumu-
lated dose with hybrid IMRT in the rCT could be very
different from that in the initial planning CT, caused by
above mentioned discrepancies and the feature differ-
ence between two CT image sets.
In a previous dosimetric evaluation study of a three-
phase ART for NPC, Fung et al. generated 2 hybrid plans
using original contours pasted on the rCTs based onCT-CT image fusion to study the accumulate dose [11].
We hypothesize that it is also reasonable to adapt the
ART for NPC patients by relying on the iCT for replan-
ning with new contours projected from a rCT based on
CT-CT image fusion. A composite plan could be easily
generated on one image set with two prescriptions,
therefore, accumulation dose could be accurately calcu-
lated, especially the accumulation dose to brainstem and
spinal cord could be accurately constrained within their
tolerant dose.
The purpose of this study is to study the feasibility of
this modified ART based on CT-CT image fusion, and
to investigate the volumetric change and dosimetric ben-
efits of this modified ART.
Figure 2 Volumetric changes between iCT and rCT. Volume changes between the initial planning CT and the rCT at the 23rd fraction;
a) contours on the initial planning CT; b) contours on the rCT; c) contours on the initial planning CT projected on the rCT after image fusion.
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Study design
As shown in Figure 1 the flowchart for the overall study
design, two image sets iCT and rCT with structures on
the iCT (SOiCT) and rCT (SOrCT) were firstly fused
based on CT-CT image fusion. With the propagation of
SOrCT on the iCT, additional set of structures on iCT
were generated (SOr-to-iCT). Dosimetric differences be-
tween VMAT replanning with SOr-to-iCT and VMAT
replanning with SOrCT were analyzed to study and
feasibility of replanning with iCT for adaptive VMAT.
Volumetric variations and resulted dosimetric effects
were also investigated to study the volume change ef-
fects during VMAT.Patients
This study was approved by the Institutional Review
Board and performed at the 1st Affiliated Hospital
of Wenzhou Medical University. We retrospectively
reviewed 28 NPC patients treated by dual arc VMAT be-
tween January 2011 and November 2012. Nine patients
had a rCT and replanning at the 23rd fraction during
their course of treatment due to observed anatomic
changes (including tumor shrinkage, nodal shrinkage
and/or weight loss). All the patients had NPC with AJCC
stage II-IV, as summarized in Table 1.Table 2 Volume changes between the initial planning CT
(iCT) and the repeat CT (rCT) at 23rd fraction
Unit(cm3) Volumes in iCT Volumes in rCT Sig (p)
GTV 78.83 ± 38.42 71.44 ± 37.46 0.42
Brainstem 28.77 ± 2.89 26.43 ± 3.03 0.22
Cord 25.52 ± 2.44 24.57 ± 2.30 0.44
Mandible 89.49 ± 14.33 89.23 ± 12.32 0.58
Left parotid 19.91 ± 4.89 11.80 ± 2.79 <0.01
Right Parotid 21.58 ± 6.16 13.29 ± 4.17 <0.01Treatment planning
Before treatment, all patients underwent immobilization
with a thermoplastic head-and-shoulder mask in the su-
pine position. CT simulation was acquired on a Philips
Brilliant spiral CT (Philips Brilliant, Cleveland, OH,
USA) according to standard procedures with 3 mm slice
spacing. Magnetic resonance images were fused into
simulation CT images to assist the target delineation.
Targets and OAR contours had been reported in our
previous study and summarized here [12]. Gross tumor
volume (GTV) was defined as the mass shown in the en-
hanced CT images, including the nasopharyngeal tumor,
retropharyngeal lymphadenopathy, and enlarged neck
nodes. Clinical target volume (CTV) was usually defined
as the GTV plus a margin of potential microscopic
spread, including the nasopharynx, retropharyngeal
nodes, clivus, skull base, pterygoid fossae, parapharyn-
geal space, inferior sphenoid sinus, posterior third of the
nasal cavity, and maxillary sinuses. Planning target
volume (PTV) was created based on target volume plus
3 mm margin, allowing for setup variability.
The prescription doses to the planning target volume
of GTV (PTVGTV) and CTV (PTVCTV) were 2.5 Gy and
2.0 Gy per fraction, respectively. Total of 28 fractions
were prescribed with a total dose of 70 Gy and 56 Gy
for PTVGTV and PTVCTV, respectively. OARs of brain-
stem, spinal cord, mandible, left and right parotid were
constrained for optimization. Dual arc VMAT plans
were optimized with the SmartArc algorithm in Pinnacle
treatment planning system (TPS) (Philips, Fichburg, WI,
USA). VMAT objective settings and optimization pa-
rameters has been reported in our previous study [13].
CT re-scanning and VMAT replanning
The rCT was acquired at the 23rd fraction for these pa-
tients due to clinically observed changes in patients’
anatomy (by inspection, palpation, and /or direct endos-
copy). Identical patient position and orientation were
maintained for two CT scans. The second CT was fused
into the iCT with rigid CT-CT image fusion based on
Figure 3 DVH comparisons between replanning based on the initial planning CT with propagated new contours from the rCT and
replanning based on the rCT.
Table 3 Detailed dosimetric comparison between
replanning based on the initial CT with propagated
contours from the repeat CT and replanning based on
the repeat CT
Initial CT Repeat CT Sig (p)
PTVGTV Dmax 1343.5 ± 65.9 1335.2 ± 29.7 0.66
PTVGTV Dmean 1253.5 ± 40.3 1244.4 ± 13.7 0.42
PTVGTV V93 96.9 ± 3.0 97.2 ± 2.6 0.79
PTVGTV V95 91.8 ± 7.2 93.0 ± 5.4 0.66
PTVCTV Dmax 1349.4 ± 61.3 1338.2 ± 29.0 0.55
PTVCTV Dmean 1083.4 ± 31.5 1078.3 ± 23.7 0.67
PTVCTV V93 98.9 ± 1.1 99.1 ± 0.9 0.12
PTVCTV V95 98.4 ± 1.3 98.7 ± 1.2 0.24
Brainstem Dmax 859.7 ± 89.1 852.8 ± 89.7 0.5
Brainstem Dmean 457.2 ± 92.3 436.9 ± 110.5 0.15
Cord Dmax 692.0 ± 29.8 690.6 ± 31.3 0.9
Cord Dmean 413.3 ± 64.2 418.7 ± 63.5 0.17
Mandible Dmax 1146.9 ± 99.5 1131.6 ± 84.5 0.38
Mandible Dmean 691.7 ± 70.2 689.8 ± 60.5 0.24
Lt parotid Dmax 1134.0 ± 143.2 1139.1 ± 103.6 0.97
Lt parotid Dmean 519.4 ± 61.3 513.2 ± 57.2 0.17
Lt parotid V5 42.1 ± 8.5 41.8 ± 7.8 0.6
Rt parotid Dmax 1144.0 ± 95.8 1162.1 ± 107.3 0.21
Rt parotid Dmean 514.9 ± 32.8 511.8 ± 40.8 0.63
Rt parotid V5 39.5 ± 4.0 39.3 ± 4.8 0.82
Note: the unit for dose is cGy; V5 = the volume receiving 5 Gy.
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ferred from the iCT into the rCT using a propagation
tool from Pinnacle3 to check the volumetric change of
this high risk volume. No dramatic changes on CTV
contours were necessary based on the physician’s deci-
sion for these patients. GTV and OARs in the rCT were
manually contoured and transferred to the iCT with the
propagation tool. For the modified ART, a replanning
VMAT plan was optimized in the iCT based on the
SOr-to-iCT. The prescription doses for PTVGTV and
PTVCTV for the remaining 5-fraction replanning VMAT
plans were 12.5 Gy and 10 Gy, respectively.
Another replanning VMAT plan in the rCT was also
optimized with identical optimization parameters and
objective settings. Dosimetric differences between these
two group replanning VMAT plans were compared to
study the feasibility of this modified ART based on CT-
CT image fusion.
The volume changes of GTV and OARs for this modi-
fied ART between the iCT and the rCT, as well as the
dosimetric effects of volumetric changes, were also in-
vestigated. The dose distribution of the initial plans for
the remaining 5 fractions were projected on SOr-to-iCT
without reoptimization to study the dosimetric effects of
anatomic changes.
Statistical analysis
Descriptive statistics were calculated to characterize the
dosimetric and volumetric changes of targets and OARs.
Comparisons between replanning in the iCT with SOr-
to-iCT and replanning in the rCT with SOrCT were an-
alyzed using paired samples t test. All statistical analyses
were conducted with SPSS 17.0 software (spss Inc.,
Chicago, IL). Differences were considered statistically
significant when p < 0.05.Results
Figure 2 shows typical volume changes of targets and
OARs between the iCT and rCT at the 23rd fraction of
one NPC patient, a) is the contours on the iCT; b) is the
contours on the rCT; and c) is the contours on the iCT
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omy was well aligned after CT-CT image fusion. CTVs
of all the NPC patients were still within physician’s ex-
pectation, therefore, no attempt had been tried to mod-
ify the contours of the CTVs. The shapes and locations
of parotids were very different on the rCT compared to
those on the iCT. Table 2 presents the quantitative
volume changes of GTV and OARs. The average volume
of GTV reduced from 78.83 ± 38.42 cm3 on the iCT to
71.44 ± 37.46 cm3 on the rCT, but with no significant
difference (p = 0.42). Except for parotids, the volume of
other OARs did not shrink very much at the 23rd frac-
tion on the rCT. The average volume of the left parotid
and right parotid were reduced from 19.91 ± 4.89 cm3
and 21.58 ± 6.16 cm3 on the iCT to 11.80 ± 2.79 cm3 and
13.29 ± 4.17 cm3 on the rCT (both p < 0.01), respectively.
Dosimetric comparisons between replanning VMAT
plans based on the iCT with SOr-to-iCT and replanning
plans based on the rCT with SOrCT were shown in
Figure 3 and Table 3. Figure 3 shows the DVH curves ofFigure 4 Typical dose distributions. A typical dose distribution of (a) the
initial planning CT, and (b) the re-optimized VMAT plan dose distribution btargets and OARs of one NPC patient optimized in two
CT sets with identical objective settings and parameters.
The curves from two replanning VMAT plans were very
close. Detailed average dosimetric characteristics were
presented in Table 3. The V95 (percent volume covered
by 95% prescription dose) of PTVGTV for replanning in
the iCT and in the rCT were 91.8 ± 7.2 and 93.0 ± 5.4
(p = 0.66), respectively. The V95 of PTVCTV in these
two replanning plans were 98.4 ± 1.3 and 98.7 ± 1.2
(p = 0.24), respectively. No significant dosimetric differ-
ence between replanning in the iCT and in the rCT was
observed.
Figure 4 shows a typical dose distribution of (a) the
original VMAT plan delivered to the new contours pro-
jected in the iCT, and (b) the re-optimized VMAT plan
dose distribution based on the new contours projected
in the iCT. The overdose delivered to the parotids due
to anatomic changes was reduced by re-optimization.
Detailed dosimetric changes due to anatomic change
were summarized in Table 4. Compared to the initialoriginal VMAT plan delivered to the new contours projected in the
ased on the new contours projected in the iCT.
Table 4 Dosimetric comparisons of without replanning in the initial CT, replanning in the initial CT
Without replannng in iCT Replanning in iCT Sig (p)
PTVGTV Dmax 1332.6 ± 42.4 1343.5 ± 65.9 0.77
PTVGTV Dmean 1257.2 ± 30.1 1253.5 ± 40.3 0.97
PTVGTV V93 98.2 ± 1.7 96.9 ± 3.0 0.12
PTVGTV V95 94.8 ± 4.7 91.8 ± 7.2 0.26
PTVCTV Dmax 1341.8 ± 40.7 1349.4 ± 61.3 0.85
PTVCTV Dmean 1087.2 ± 20.7 1083.4 ± 31.5 0.91
PTVCTV V93 99.2 ± 0.7 98.9 ± 1.1 0.27
PTVCTV V95 98.8 ± 0.9 98.4 ± 1.3 0.62
Brainstem Dmax 844.7 ± 95.4 859.7 ± 89.1 0.94
Brainstem Dmean 448.5 ± 76.4 457.2 ± 92.3 0.84
Cord Dmax 695.5 ± 44.2 692.0 ± 29.8 0.87
Cord Dmean 409.0 ± 54.7 413.3 ± 64.2 0.82
Mandible Dmax 1128.2 ± 95.0 1146.9 ± 99.5 0.76
Mandible Dmean 705.4 ± 70.9 691.7 ± 70.2 0.91
Lt parotid Dmax 1138.7 ± 114.6 1134.0 ± 143.2 0.99
Lt parotid Dmean 581.9 ± 87.1 519.4 ± 61.3 0.05
Lt parotid V5 49.9 ± 12.3 42.1 ± 8.5 0.01
Rt parotid Dmax 1151.8 ± 108.1 1144.0 ± 95.8 0.75
Rt parotid Dmean 581.2 ± 79.8 514.9 ± 32.8 0.02
Rt parotid V5 50.7 ± 8.3 39.5 ± 4.0 0.001
Note: the unit for dose is cGy, V5 = the volume receiving 5 Gy.
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otid after re-optimization were decreased by 62.5 cGy
(p = 0.05) and 67.3 cGy (p = 0.02), respectively, and the
V5 (the volume receiving 5 Gy) of the left and right pa-
rotids were decreased by 7.8% (p = 0.01) and 11.2%
(p = 0.001), respectively. No significant differences on
the coverage of PTVGTV and PTVCTV and the dose de-
livered to other OARs were observed between the initial
plans and re-optimized plans.Discussion
In this study, we evaluated the feasibility of a modified
ART based on CT-CT image fusion. Our results indi-
cated it’s feasible and accurate to based on CT-CT image
fusion to treat NPC patients adaptively with replanning
in the iCT with new contours projected from rCT. This
study also demonstrated the importance of replanning
for parotid protection during the VMAT treatment of
NPC patients.
Based on CT-CT image fusion, DVHs and dosimetric
characteristics of the replanning VMAT plans in the iCT
with new contours projected from the rCT did not demon-
strate significant difference compared to those of the re-
planning VMAT plans in the rCT directly. This results
indicated instead of replanning in a different rCT set and
transferring the original IMRT plan into the rCT, it isfeasible to replan in the iCT and accumulate the dose based
on CT-CT image fusion, using the rCT as a contour
reference.
In this study, tremendous volume shrinkage of parotids
were observed at the 23rd fraction after a dose of 46 Gy to
PTVCTV and 57.5 Gy to PTVGTV, respectively. The average
shrinkage volumes of left parotid and right parotid were
about 3.56 cm3 and 2.45 cm3, respectively. It was about
average 24.9% and 15.2% of their initial volumes, respect-
ively. This finding was similar to the reported results in pre-
vious studies. Barker et al. observed a median parotid
volume loss of 28.1% at the end of treatment [14]. A largest
average absolute volume shrinkage of 10 cm3 of parotids
was observed at the 7th week for oropharyngeal cancer
IMRT treatment in another study [15]. There were other
different absolute and percentage volume changes of pa-
rotids were reported [16,17]. These differences might due
to the differences in the prescription dose, the treatment
fraction for the rCT, patient weight loss, and the prevalence
of chemotherapy. No significant volume changes of other
OARs was observed. There was also no significant volume
changes for GTV between the iCT and the rCT (p = 0.66).
Similar results were reported in the previous study for
head-and-neck patients and NPC patients with rCTs [6,8].
Various dosimetric effects of position shift and anatomic
changes on targets and OARs have been reported by differ-
ent replanning studies. A dose decrease of 0.8-6.3 Gy and
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92% of head-and-neck patients were reported by Hansen
et al. [6]. Zhao et al. reported a dose decrease to CTV, but
no dose decrease to GTV was observed for NPC patients
[8]. Similar results were reported in the study of Wang
et al. for NPC patients [7]. In our study, there was also no
significant difference on the PTVGTV coverage observed for
new contours with and without re-optimization after CT-
CT image fusion. In this study, the physicians decided not
to change the CTV volume to ensure an adequate coverage
for this high risk volume, so no dosimetric difference for
CTV was reported.
No difference on the maximum dose of spinal cord
was observed with and without replanning in our study,
this was different from the reported results in previous
two studies [6,8]. The dosimetric effects on brainstem
and mandible was consistent with previous studies with-
out significant effects [7,8]. It has been reported that the
effect of volume changes of parotid glands is particularly
important for patients with oro-and rhinopharynx tu-
mors, in which the medial shift of the parotid corre-
sponds to a shift toward the high-dose coverage region
[15,18]. Similar dosimetric effects were demonstrated in
our study. Replanning based on the new contours from
rCT could decrease the mean dose the V5 for both
parotids.
In this study, the patients with a rCT at the 23rd frac-
tion were enrolled in the sake of data analysis consist-
ence. Due to the difference in the prescription dose per
fraction and the difference in the patient response, dif-
ferent time point for the rCT has been reported. Wang
et al. suggested a necessary of rCT before 25th fraction
for NPC patients [7]. Zhao et al. reported their rCT
before 20th fraction [8]. Currently, clinician’s judgment
plays the most important role in determining the need
for a new CT scan based on the clinical observation.
Future studies on identifying specific predictive factors
for a rCT during radiotherapy will be helpful to realize
the full benefits of adaptive radiotherapy.Conclusion
Patients with NPC undergoing dual arc VMAT had
significant anatomic changes and dosimetric variations
to parotids. It’s feasible to replanning in the iCT with
contours propagated from a rCT based on CT-CT
image fusion. It was accurate enough to identify the
volume changes and to ensure safe dose to parotids
with our modified adaptive radiotherapy scheme
based on CT-CT image fusion for NPC patients. Fu-
ture rCT and replanning study on other tumor sites
will help to further verify the accuracy of CT-CT
image fusion for this modified adaptive radiotherapy
technique.Consent
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